Effects of Testosterone on Muscle Strength, Physical Function, Body Composition, and Quality of Life in Intermediate-Frail and Frail Elderly Men: A Randomized, Double-Blind, Placebo-Controlled Study
The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Abstract
CONTEXT: Physical frailty is associated with reduced muscle strength, impaired physical function, and quality of life. Testosterone (T) increases muscle mass and strength in hypogonadal patients. It is unclear whether T has similar effects in intermediate-frail and frail elderly men with low to borderline-low T. OBJECTIVE: Our objective was to determine the effects of 6 months T treatment in intermediate-frail and frail elderly men, on muscle mass and strength, physical function, and quality of life. DESIGN AND SETTING: We conducted a randomized, double-blind, placebo-controlled, parallel-group, single-center study. PARTICIPANTS: PARTICIPANTS were community-dwelling intermediate-frail and frail elderly men at least 65 yr of age with a total T at or below 12 nmol/liter or free T at or below 250 pmol/liter. METHODS: Two hundred seventy-four participants were randomized to transdermal T (50 mg/d) or placebo gel for 6 months. Outcome measures included muscle strength, lean and fat mass, physical function, and self-reported quality of life. RESULTS: Isometric knee extension peak torque improved in the T group (vs. placebo at 6 months), adjusted difference was 8.6 (95% confidence interval, 1.3-16.0; P = 0.02) Newton-meters. Lean body mass increased and fat mass decreased significantly in the T group by 1.08 +/- 1.8 and 0.9 +/- 1.6 kg, respectively. Physical function improved among older and frailer men. Somatic and sexual symptom scores decreased with T treatment; adjusted difference was -1.2 (-2.4 to -0.04) and -1.3 (-2.5 to -0.2), respectively. CONCLUSIONS: T treatment in intermediate-frail and frail elderly men with low to borderline-low T for 6 months may prevent age-associated loss of lower limb muscle strength and improve body composition, quality of life, and physical function. Further investigations are warranted to extend these results.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elsewhere, testosterone-associated increases in lean mass were accompanied by improvements in handgrip strength, knee extension and leg press and chest press exercises415,416.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [415]
In the citing paper
“Increasing serum testosterone levels to low- to mid-normal ranges through the administration of testosterone for several months in healthy older men resulted in increased muscle strength (133–136) and improved physical performance (134, 135).”
From Health Consequences of Sarcopenic Obesity: A Narrative Review (2020) · cites this paper as [135]
In the citing paper
“Testosterone supplementation is also shown to benefit other aspects of health, including sexual function, physical function, vitality, quality of life and improved mood [109, 111].”
From Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review (2019) · cites this paper as [109]
In the citing paper
“Several trials conducted with testosterone show a direct effect on muscle mass and, in several cases, on muscle strength and performance, with a slight reduction in body fat, and some effect on bone density [107-110].”
From Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review (2019) · cites this paper as [109]
In the citing paper
“Most randomized, placebo-controlled trials have indicated that T treatment increases lean mass and reduces fat mass in men with low serum T [2–7]”
From Causal relationship between obesity and serum testosterone status in men: A bi-directional mendelian randomization analysis (2017) · cites this paper as [6]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907 · cited 16×
“, Los Angeles, CA) was assessed by calculating average PT of three maximal isometric contractions (kilograms) in the dominant hand, after a practice session, using the methodology of the Cardiovascular Health Study (1).”
BackgroundMethodInfluentialA Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824 · cited 1×
“Free T was calculated using the Vermeulen equation (27).”
MethodPerformance‐Oriented Assessment of Mobility Problems in Elderly Patients
Tinetti, M. E. (1986) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1986.tb05480.x · Cited by 3,352 · cited 3×
“0 (24) Nm in the T and placebo groups, respectively, at 6 months compared with baseline.”
MethodResultThe physical activity scale for the elderly (PASE): Development and evaluation
Washburn, R. A., Smith, K. W., Jette, A. M., & Janney, C. A. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90053-4 · Cited by 3,177 · cited 1×
“Self-reported physical activity was assessed using the Physical Activity Scale of the Elderly (PASE) questionnaire (25).”
MethodHigh-Intensity Strength Training in Nonagenarians: Effects on Skeletal Muscle
Fiatarone, M. A. (1990) · JAMA · doi:10.1001/jama.1990.03440220053029 · Cited by 1,593
Is the Placebo Powerless?: An Analysis of Clinical Trials Comparing Placebo with No Treatment
Hróbjartsson, A., & Gøtzsche, P. C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105243442106 · Cited by 1,503
Testosterone Replacement in Older Hypogonadal Men: A 12-Month Randomized Controlled Trial
Sih, R. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.6.1661 · Cited by 922
An Objective Measure of Physical Function of Elderly Outpatients: The Physical Performance Test
Reuben, D. B., & Siu, A. L. (1990) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1990.tb01373.x · Cited by 728
Extent of motor unit activation during effort
Belanger, A. Y., & McComas, A. J. (1981) · Journal of Applied Physiology · doi:10.1152/jappl.1981.51.5.1131 · Cited by 579 · cited 1×
“PT of three maximal IME and IMF contractions was measured with twitch interpolation (19) to ensure maximal muscle contraction.”
MethodDHEA in elderly women and DHEA or testosterone in elderly men.
Nair, K. S., Rizza, R. A., O'Brien, P., Dhatariya, K., Short, K. R., Nehra, A., Vittone, J. L., Klee, G. G., Basu, A., Basu, R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054629 · Cited by 566 · cited 2×
“Indeed, most previous studies (8, 9, 36, 41, 45) among healthy men have not demon-”
BackgroundMethodPage, S. T., Amory, J. K., Bowman, F. D., Anawalt, B. D., Matsumoto, A. M., Bremner, W. J., & Tenover, J. L. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1933 · Cited by 566
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Mac, R. P., Lee, M., Yarasheski, K. E., Sinha-Hikim, I., Dzekov, C., Dzekov, J., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1184 · Cited by 544
Effect of Testosterone Treatment on Body Composition and Muscle Strength in Men Over 65 Years of Age
Snyder, P. J. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2647 · Cited by 531 · cited 7×
“(8) reported improvement in perception of physical functioning but not other domains of Short Form 36 among elderly men.”
BackgroundResultInfluentialFerrando, A. A., Sheffield-Moore, M., Yeckel, C. W., Gilkison, C., Jiang, J., Achacosa, A., Lieberman, S. A., Tipton, K., Wolfe, R. R., & Urban, R. J. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00362.2001 · Cited by 522 · cited 1×
“There are limited data on the beneficial effects of T on lower limb muscle strength in elderly men (12, 13).”
BackgroundEmmelot-Vonk, M. H., Verhaar, H. J. J., Nakhai Pour, H. R., Aleman, A., Lock, T. M. T. W., Bosch, J. L. H. R., Grobbee, D. E., & van der Schouw, Y. T. (2008) · JAMA · doi:10.1001/jama.2007.51 · Cited by 518
Chandler, J. M., Duncan, P. W., Kochersberger, G., & Studenski, S. (1998) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/s0003-9993(98)90202-7 · Cited by 461 · cited 1×
“The improvement in IME-PT we observed is recognized as functionally significant; an increase in knee extension PT of around 5 Nm has been shown to be associated with improvements in physical function (31).”
BackgroundBrambilla, D. J., Matsumoto, A. M., Araujo, A. B., & McKinlay, J. B. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1902 · Cited by 448 · cited 2×
“Although there is significant intra-individual variation in T levels, suggesting that more than one measurement should be included at baseline (48), this tends to be less marked among the elderly (49), and our placebo group results confirmed that T levels were stable over time (Fig.”
Effects of Testosterone and Resistance Training in Men with Chronic Obstructive Pulmonary Disease
Casaburi, R., Bhasin, S., Cosentino, L., Porszasz, J., Somfay, A., Lewis, M. I., Fournier, M., & Storer, T. W. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200305-617oc · Cited by 388 · cited 2×
“Men with chronic obstructive pulmonary disease (14), those receiving glucocorticoids (15), and elderly men in rehabilitation (16) treated with T showed improvements in muscle strength or physical function.”
BackgroundResultWittert, G. A., Chapman, I. M., Haren, M. T., Mackintosh, S., Coates, P., & Morley, J. E. (2003) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/58.7.m618 · Cited by 345 · cited 4×
“The greater inherent variability associated with dynamometry (38) may limit its ability to detect relatively small improvements in muscle strength (8, 10, 11).”
BackgroundResultInfluentialIsokinetic Dynamometry: Applications and Limitations
Baltzopoulos, V., & Brodie, D. A. (1989) · Sports Medicine · doi:10.2165/00007256-198908020-00003 · Cited by 283 · cited 1×
“The greater inherent variability associated with dynamometry (38) may limit its ability to detect relatively small improvements in muscle strength (8, 10, 11).”
BackgroundMorphology and enzymatic capacity in arm and leg muscles in 78–81 year old men and women
GRIMBY, G., DANNESKIOLD‐SAMSØE, B., HVID, K., & SALTIN, B. (1982) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1982.tb07054.x · Cited by 280 · cited 1×
“It is well known that muscle strength decreases with age, at approximately 1% per year, even in physically active men (28).”
BackgroundThe Short-Term Effects of High-Dose Testosterone on Sleep, Breathing, and Function in Older Men
Liu, P. Y., Yee, B., Wishart, S. M., Jimenez, M., Jung, D. G., Grunstein, R. R., & Handelsman, D. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030236 · Cited by 275 · cited 9×
“Many previous studies have been unable to report improvement in QoL (9, 41).”
BackgroundMethodInfluentialTestosterone injection stimulates net protein synthesis but not tissue amino acid transport
Ferrando, A. A., Tipton, K. D., Doyle, D., Phillips, S. M., Cortiella, J., & Wolfe, R. R. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.5.e864 · Cited by 256
Crawford, B. A. L., Liu, P. Y., Kean, M. T., Bleasel, J. F., & Handelsman, D. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021827 · Cited by 237 · cited 5×
“(15), treating elderly men on glucocorticoids with T and nandrolone decanoate, demonstrated improvements in lower limb muscle strength measured by dynamometry (IKE and IKF).”
BackgroundResultInfluentialEffects of age on human muscle torque, velocity, and power in two muscle groups
Lanza, I. R., Towse, T. F., Caldwell, G. E., Wigmore, D. M., & Kent-Braun, J. A. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00724.2002 · Cited by 210 · cited 1×
“Furthermore, there is evidence that age-related loss of physical function preferentially affects knee extensor muscle groups (29, 30).”
BackgroundBrambilla, D. J., O'Donnell, A. B., Matsumoto, A. M., & McKinlay, J. B. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02976.x · Cited by 207 · cited 1×
“Although there is significant intra-individual variation in T levels, suggesting that more than one measurement should be included at baseline (48), this tends to be less marked among the elderly (49), and our placebo group results confirmed that T levels were stable over time (Fig.”
Testosterone and Growth Hormone Improve Body Composition and Muscle Performance in Older Men
Sattler, F. R., Castaneda-Sceppa, C., Binder, E. F., Schroeder, E. T., Wang, Y., Bhasin, S., Kawakubo, M., Stewart, Y., Yarasheski, K. E., Ulloor, J., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2338 · Cited by 194 · cited 3×
“(13) reported improvement in lower limb muscle strength of over 200 and 23%, respectively, using one-repetition maximum (1-RM).”
BackgroundMethodResultBrill, K. T., Weltman, A. L., Gentili, A., Patrie, J. T., Fryburg, D. A., Hanks, J. B., Urban, R. J., & Veldhuis, J. D. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020098 · Cited by 188 · cited 1×
“Most previous T interventional studies on healthy elderly men did not measure (6, 34) or were unable to demonstrate (7, 8, 11, 35) improvements in lower limb strength.”
BackgroundKryger, A. I., & Andersen, J. L. (2007) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1111/j.1600-0838.2006.00575.x · Cited by 175 · cited 1×
“IME- and IKE-PT were used as primary outcome measures (17, 18).”
MethodSchaap, L. A., Pluijm, S. M. F., Smit, J. H., Van Schoor, N. M., Visser, M., Gooren, L. J. G., & Lips, P. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02315.x · Cited by 168 · cited 2×
“In cross-sectional and longitudinal studies, lower sex hormone levels are associated with greater dependency, impaired balance, and falls, whereas higher levels are associated with better performance of activities of daily living (3, 4).”
BackgroundGiannoulis, M. G., Sonksen, P. H., Umpleby, M., Breen, L., Pentecost, C., Whyte, M., McMillan, C. V., Bradley, C., & Martin, F. C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0957 · Cited by 164 · cited 1×
“Treatment with GH and T (40) and recombinant human chorionic gonadotropin (41) in healthy elderly men showed no improvement in muscle strength measured by dynamometry.”
MethodSvartberg, J., Agledahl, I., Figenschau, Y., Sildnes, T., Waterloo, K., & Jorde, R. (2008) · International Journal of Impotence Research · doi:10.1038/ijir.2008.19 · Cited by 160 · cited 1×
“(46) reported a nonsignificant mean change in AMS somatic and sexual subscales of 0.”
BackgroundBhasin, S., Parker, R. A., Sattler, F., Haubrich, R., Alston, B., Umbleja, T., Shikuma, C. M., & for the AIDS Clinical Trials Group Protocol A5079 Study Team (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2060 · Cited by 151 · cited 1×
“Our results corroborate studies that have demonstrated increased LBM and decreased FM with T in healthy (7, 8, 11, 13) and in elderly men with chronic illness (14, 15, 44).”
ResultStorer, T. W., Woodhouse, L., Magliano, L., Singh, A. B., Dzekov, C., Dzekov, J., & Bhasin, S. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01927.x · Cited by 145 · cited 1×
“Indeed, most previous studies (8, 9, 36, 41, 45) among healthy men have not demon-”
BackgroundSzulc, P., Claustrat, B., Marchand, F., & Delmas, P. D. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030200 · Cited by 134 · cited 3×
“In cross-sectional and longitudinal studies, lower sex hormone levels are associated with greater dependency, impaired balance, and falls, whereas higher levels are associated with better performance of activities of daily living (3, 4).”
BackgroundEffect of Testosterone Administration on Sexual Behavior and Mood in Men with Erectile Dysfunction
Schiavi, R. C., White, D., Mandeli, J., & Levine, A. C. (1997) · Archives of Sexual Behavior · doi:10.1023/a:1024518730222 · Cited by 132 · cited 1×
“The improvement in sexual symptoms such as libido, sexual performance, and morning erections in the current study was expected from results of previous studies (34, 47).”
ResultTestosterone Improves Rehabilitation Outcomes in Ill Older Men
Bakhshi, V., Elliott, M., Gentili, A., Godschalk, M., & Mulligan, T. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb05002.x · Cited by 126 · cited 2×
“Men with chronic obstructive pulmonary disease (14), those receiving glucocorticoids (15), and elderly men in rehabilitation (16) treated with T showed improvements in muscle strength or physical function.”
BackgroundNeuromuscular and balance responses to flywheel inertial versus weight training in older persons
Onambélé-Pearson, G. L., Maganaris, C. N., Mian, O. S., Tam, E., Rejc, E., McEwan, I. M., & Narici, M. V. (2008) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2008.09.004 · Cited by 117 · cited 1×
“(43) demonstrated strength gains among elderly men after resistance training.”
BackgroundSvartberg, J., Aasebø, U., Hjalmarsen, A., Sundsfjord, J., & Jorde, R. (2004) · Respiratory Medicine · doi:10.1016/j.rmed.2004.02.015 · Cited by 114
Testosterone Supplementation for Aging-Associated Sarcopenia
Bhasin, S. (2003) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/58.11.m1002 · Cited by 114 · cited 20×
“J Clin Endocrinol Metab, February 2010, 95(2):0000–0000 jcem.”
BackgroundInfluentialIs the Placebo Powerless? An Analysis of Clinical Trials Comparing Placebo With no Treatment
Hróbjartsson, A., & Gøtzsche, P. C. (2001) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200110000-00021 · Cited by 103 · cited 1×
“However, some of the apparent improvement may be due to a significant placebo effect known to be substantial in objective measures of physical parameters (32, 33).”
BackgroundClague, J. E., Wu, F. C. W., & Horan, M. A. (1999) · International Journal of Andrology · doi:10.1046/j.1365-2605.1999.00177.x · Cited by 98 · cited 3×
“The greater inherent variability associated with dynamometry (38) may limit its ability to detect relatively small improvements in muscle strength (8, 10, 11).”
BackgroundSelf-citationMeissner, K., Distel, H., & Mitzdorf, U. (2007) · BMC Medicine · doi:10.1186/1741-7015-5-3 · Cited by 86
McCarthy, C. J. (2004) · Rheumatology · doi:10.1093/rheumatology/keh081 · Cited by 65 · cited 5×
“Tinetti gait and balance, ALF, 6MWT, and PPT im- proved at 6-month assessment (vs. baseline) in the T group.”
MethodInfluentialCapodaglio, P. (2005) · Age and Ageing · doi:10.1093/ageing/afi050 · Cited by 65 · cited 1×
“IME- and IKE-PT were used as primary outcome measures (17, 18).”
MethodAging Males' Symptoms scale: a standardized instrument for the practice.
Heinemann, L. A. J. (2005) · PubMed · Cited by 57
Andriole, G. L. (2008) · Yearbook of Urology · doi:10.1016/s0084-4071(08)79088-2 · Cited by 55 · cited 9×
“Many previous studies have been unable to report improvement in QoL (9, 41).”
BackgroundResultInfluentialHarridge, S. D. R., Magnusson, G., & Gordon, A. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014971 · Cited by 52 · cited 2×
“Frailty criteria present, n (%) Exhaustion 65 (49) 68 (52) Weight loss 32 (24) 26 (20) Physical activity 21 (16) 13 (10) Walk time 11 (8) 9 (7) Grip strength 81 (62) 81 (62) No.”
MethodLy, L. P., & Handelsman, D. J. (2002) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2002.03606.x · Cited by 40 · cited 1×
“It is well recognized that dynamometry is effort dependent and affected by motivation, mood, and fatigue (37).”
BackgroundInfluence of Age on Isometric, Isotonic, and Isokinetic Force Production Characteristics in Men
Runnels, E. D., Bemben, D. A., Anderson, M. A., & Bemben, M. G. (2005) · Journal of Geriatric Physical Therapy · doi:10.1519/00139143-200512000-00003 · Cited by 34 · cited 1×
“Furthermore, there is evidence that age-related loss of physical function preferentially affects knee extensor muscle groups (29, 30).”
BackgroundJankowski, C. M. (2009) · Yearbook of Sports Medicine · doi:10.1016/s0162-0908(09)79424-3 · Cited by 13
Meikle, A. W., & Molitch, M. E. (2007) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)70210-5 · Cited by 5
Testosterone and Growth Hormone Improve Body Composition and Muscle Performance in Older Men
Nieman, D. C. (2010) · Yearbook of Sports Medicine · doi:10.1016/s0162-0908(09)79607-2 · Cited by 4
Influence of Age on Isometric, Isotonic, and Isokinetic Force Production Characteristics in Men
Bemben, M. G., Runnels, E. D., Bemben, D. A., & Anderson, M. A. (2004) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-200405001-01715 · Cited by 4
Cited by
A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans
Morley, J. E., Malmstrom, T. K., & Miller, D. K. (2012) · The Journal of nutrition, health and aging · doi:10.1007/s12603-012-0084-2 · Cited by 1,987
“Evidence is emerging that targeted therapies may decrease the negative outcomes associated with being frail (4-6).”
BackgroundTestosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00229 · Cited by 1,736
“In placebo-controlled trials in healthy and mobility-limited older men, T therapy resulted in greater gains in lean body mass (LBM), maximal voluntary strength, muscle power, and some performance-based measures of physical function vs placebo (79 – 83).”
Self-citationAdverse Events Associated with Testosterone Administration
Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell, W. R., Jette, A. M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000485 · Cited by 1,494
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
Batsis, J. A., & Villareal, D. T. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0062-9 · Cited by 1,382
Muscle wasting in disease: molecular mechanisms and promising therapies
Cohen, S., Nathan, J. A., & Goldberg, A. L. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4467 · Cited by 1,089
Metadata
- Authors
- Srinivas-Shankar, U., Roberts, S. A., Connolly, M. J., O'Connell, M. D. L., Adams, J. E., Oldham, J. A., & Wu, F. C. W.
- Affiliations
- Manchester Royal Infirmary (GB)
- University of Manchester (GB)
- University of Auckland (NZ)
- Corresponding author
- Wu, Frederick C. W.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2010-02
- Volume
- 95
- Issue
- 2
- Pages
- 639-650
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2056150258
- Cited by
- 629
- References
- 55
- Citations by year
- 2026: 6 · 2025: 21 · 2024: 26 · 2023: 34 · 2022: 33 · 2021: 22 · 2020: 24 · 2019: 34 · 2018: 40 · 2017: 51 · 2016: 51 · 2015: 49 · 2014: 64 · 2013: 45 · 2012: 48
- FWCI
- 41.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- ResearchSpace (University of Auckland) (submittedVersion)
- Funders
- Eli Lilly and Company
- Wellcome Trust
- Manchester Biomedical Research Centre
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
- Keywords
- testosterone replacement therapy, frailty, older men, muscle strength, physical function, body composition, lean body mass, quality of life, transdermal testosterone, hypogonadism, age-related muscle loss, somatic symptoms, sexual symptoms
- MeSH terms
- Aged, Body Composition, Double-Blind Method, Postural Balance, Gait, Humans, Male, Motor Activity, Quality of Life, Testosterone, Frail Elderly, Muscle Strength
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.